COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 131 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $271,000 | -71.3% | 23,591 | -67.1% | 0.04% | -65.1% |
| Q2 2019 | $944,000 | -3.3% | 71,802 | +11.3% | 0.11% | +7.1% |
| Q1 2019 | $976,000 | -14.5% | 64,489 | -2.9% | 0.10% | -25.0% |
| Q4 2018 | $1,141,000 | +0.6% | 66,437 | -13.6% | 0.13% | +109.5% |
| Q3 2018 | $1,134,000 | +9.0% | 76,900 | +76.4% | 0.06% | +21.2% |
| Q2 2018 | $1,040,000 | – | 43,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $2,364,000 | 4.71% |
| GREAT POINT PARTNERS LLC | 861,410 | $20,364,000 | 4.27% |
| Rubric Capital Management LP | 2,420,214 | $57,214,000 | 3.60% |
| Camber Capital Management LP | 2,000,000 | $47,280,000 | 1.59% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 416,244 | $9,840,000 | 1.10% |
| Eventide Asset Management | 2,629,593 | $62,164,000 | 0.84% |
| RICE HALL JAMES & ASSOCIATES, LLC | 799,298 | $18,895,000 | 0.67% |
| EMERALD ADVISERS, LLC | 741,278 | $17,524,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 790,391 | $18,685,000 | 0.61% |
| Values First Advisors, Inc. | 37,222 | $880,000 | 0.60% |